A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites - 05/09/11
Abstract |
Background: Interest in complementary therapies in the United States is rising. We sought to characterize the use of complementary therapies among our cancer patients in our community and analyze differences in use between patients with breast versus those with other primary tumor sites.
Methods: A survey of 1,935 randomly selected patients from the tumor registry was performed. A questionnaire was mailed to 935 breast cancer patients and 1,000 patients with other primary site diagnoses.
Results: There were 617 responses (288 breast, 329 other). Seventy-five patients (75%) reported use of a complementary modality. Top therapies used were nutrition (63%), massage (53%), and healing herbs (44%). The most common reason for use, immune modulation (73%), was similar in both groups. Therapy was used consistently by 84% of breast patients versus 66% of others (P = 0.003).
Conclusion: A significant number of cancer patients are using complementary therapies. Breast cancer patients are far more likely to be consistent users compared with other tumor sites.
Le texte complet de cet article est disponible en PDF.Plan
Vol 179 - N° 5
P. 407-411 - mai 2000 Retour au numéro
Article précédent
- Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40
- Trygg Ramstad, Lyle Lawnicki, John Vetto, Andrew Weinberg
- An analysis of breast cancer surgery after free transverse rectus abdominis myocutaneous (TRAM) flap reconstruction
- Alison C Ross, Conrad H Rusnak, Mark K Hill, J.David Naysmith, Sandra L Taylor, William E Dunlop, Allan H Hayashi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?